Antarza

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Antarza

This section provides an authoritative definition of the medicine's identity, classification, and general purpose.

Property Description
Active ingredient Risperidone (INN)
Form Tablet, oral solution, extended-release injection
Pharmacological class Atypical Antipsychotic (Second-Generation)
General purpose Chemical modulation and mood stabilization
Origin Synthetic drug (Benzisoxazole derivative)

What Type of Medicine is Antarza (Risperidone)?

Antarza is the trade name for the prescription-only active ingredient Risperidone, which is a synthetic psychotropic agent chemically classified as a Benzisoxazole derivative. It is categorized as a Second-Generation Antipsychotic (SGA), commonly known as an Atypical Antipsychotic. This medicine is utilized for the management of severe psychological distress and is indicated for stabilizing thought and mood disorders. Its distinction lies in its pharmacological action as a serotonin-dopamine antagonist (SDA); this dual-receptor approach is a central component in the treatment of chronic psychiatric conditions, offering a different physiological profile than older, first-generation medications.


Available Forms and General Therapeutic Purpose

Risperidone is manufactured as a single active ingredient product in various forms, including the standard oral tablet, the oral solution, the orally disintegrating tablet (ODT), and formulations for extended-release intramuscular injection. This array of formulations, particularly the long-acting injectable suspensions, provides options for administration via the oral or intramuscular route. The medicine's overall function as a psychotropic agent is to facilitate a more stable neurochemical balance within the central nervous system. This action is directed toward regulating emotional instability and addressing persistent disturbances to support emotional control and clarity of thought, which are the primary therapeutic goals for this class of medicine.

Regulatory References

  1. Risperidone - StatPearls - NCBI Bookshelf

What side effects are possible with Antarza?

Possible Side Effects and Safety Information

The safety profile of Antarza (Risperidone) is formally defined by regulatory agencies, classifying potential adverse reactions by both frequency and the body system affected.

Adverse Reaction Classification

Side effects documented in official labeling primarily affect the Nervous System (e.g., movement disorders, sedation), Metabolism and Nutrition (e.g., weight gain, increased appetite), and the Gastrointestinal System.

Frequency Category Examples of Documented Adverse Reactions
Very Common (1/10) Parkinsonism, Headache, Insomnia, Somnolence/Sedation
Common (1/100 to < 1/10) Akathisia, Dizziness, Weight increased, Nausea, Vomiting

Serious Safety Considerations

Official prescribing information highlights specific, less frequent but clinically significant adverse reactions. These include Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia (a syndrome of involuntary movements), and severe metabolic changes such as Hyperglycemia or Diabetes Mellitus. Additionally, Cerebrovascular Events (like stroke) are documented as a serious safety concern.

Population and Time-Related Safety Notes

Regulatory documents contain specific safety notes for certain populations and exposure periods. There is an officially stated increased risk of mortality and stroke-related events in older adults with dementia-related psychosis (a non-approved use). Furthermore, some effects are related to the timeline of use: Orthostatic Hypotension is noted to be more common during the initial dose titration, while the risk of Tardive Dyskinesia increases with the duration of treatment. The label also notes the potential for Cognitive and Motor Impairment.

Overdose and Emergency Response

A suspected overdose of Antarza (Risperidone) requires seeking immediate medical attention. Regulators mandate contacting a poison control center and remaining under close medical supervision until full recovery, particularly given the risk of severe complications.


The officially documented clinical manifestations of an overdose are typically an exaggeration of the drug's known pharmacological effects, primarily involving the Central Nervous System (CNS) and the Cardiovascular System. Clinical signs may include profound drowsiness, sedation, tachycardia, and hypotension. Severe outcomes listed in regulatory documents involve the potential for convulsions and life-threatening Ventricular Arrhythmia, which is often associated with a prolonged QT interval. Pediatric patients are noted to have an increased susceptibility to severe Extrapyramidal Symptoms (EPS).

Since no specific antidote is known for Risperidone, treatment is strictly symptomatic and supportive. Management protocols emphasize ensuring an adequate airway and continuous cardiac monitoring due to the severe cardiovascular risks. Furthermore, regulatory guidance warns that certain agents, such as Epinephrine and Dopamine, must be avoided when treating low blood pressure during an overdose.

Therapeutic Uses of Antarza

What Antarza Treats: Main Uses and Benefits

Antarza (Risperidone) is used within clinical settings to manage symptoms across key psychiatric domains, offering supportive relief for patients experiencing acute, severe, or recurrent manifestations. This medicine is generally used to treat Schizophrenia, Bipolar I Disorder (acute manic or mixed episodes), and irritability associated with Autistic Disorder.


Symptom Relief and Stabilization

The medication is commonly used across conditions characterized by periods of heightened symptoms, notably addressing psychotic thought disturbances and extreme emotional dysregulation. It helps manage symptom clusters that may appear suddenly, providing symptomatic relief for pronounced difficulties like hallucinations, delusions, severe agitation, and elevated mood. Applied during phases of increased distress or discomfort, the medicine helps support patients by easing distress and assisting with the maintenance of functional stability.

Quick Fact: Relief for Severe Behavioral Dysregulation

For pediatric patients, the medicine is relevant in contexts involving heightened systemic burden for severe behavioral outbursts, and is commonly used for managing aggression, intense temper tantrums, and actions related to self-injury associated with Autistic Disorder.

“The goal is to offer symptomatic relief that helps address functional strain caused by severe manifestations.”

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Antarza (Risperidone) — Official Regulatory Information

Antarza (risperidone) use is strictly defined by regulatory eligibility rules concerning age, physiological state, and pre-existing medical conditions.


Contraindicated Populations

Patients who must not use the medicine include individuals with known hypersensitivity to risperidone or any component of the formulation. The medicine is also not approved for, and carries a Boxed Warning against, use in elderly patients with dementia-related psychosis due to a documented increased risk of death.


Age-Related Eligibility Rules

Approved Use Minimum Age Established by Regulation
Schizophrenia 13 years of age
Bipolar Mania 10 years of age
Autistic Irritability 5 years of age

Safety and effectiveness are not established for use below these age thresholds for the corresponding conditions. Use in adults is approved for all labeled conditions.


Condition-Specific Restrictions

  • Organ Function: Use requires caution in patients with severe renal (kidney) or hepatic (liver) impairment, where a modified starting regimen is explicitly advised in the labeling.
  • Cardiovascular/Neurological: Caution is required in patients with pre-existing cardiovascular disease, conditions that predispose to hypotension, or a history of seizures.
  • Pregnancy/Lactation: Use during pregnancy (especially the third trimester) requires monitoring of the neonate. For breastfeeding mothers, the label advises a decision to discontinue nursing or discontinue the drug due to risperidone being excreted into human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Antarza is subject to metabolism by the Cytochrome P450 3A4 (CYP3A4) enzyme in the body. As a result, its systemic exposure is sensitive to medicinal products that inhibit this enzyme system.

Documented Pharmacokinetic Interactions

Concomitant use with strong or moderate CYP3A4 inhibitors results in a clinically significant increase in the concentration (AUC and C max) of Antarza in the bloodstream. This effect is due to the inhibition of the enzyme responsible for Antarza's breakdown. An example of a strong CYP3A4 inhibitor is Itraconazole, which is explicitly noted to increase Antarza exposure.

Interaction Management Constraints

The most important constraint involves a mandatory dose adjustment. Official labeling requires that the Antarza dose be reduced when it is co-administered with any strong or moderate CYP3A4 inhibitor. This dose modification is from the standard 150 mg once daily dose to 100 mg once daily to manage the increased exposure and mitigate potential related risks. Avoidance of concurrent use may also be necessary in certain contexts, as dictated by clinical judgment regarding the severity of the expected concentration increase. No specific timing-based spacing requirements are officially documented.

Mechanism of Action

Antarza is a centrally-acting pharmaceutical agent, distributed across the blood-brain barrier. Its primary mechanism involves antagonistic activity at multiple neurotransmitter receptors, chiefly dopamine Type 2 (D2) and serotonin Type 2A (5-HT2A) receptors within the brain. It exhibits a higher binding affinity for 5-HT2A receptors compared to D2 receptors.

Antarza functions as an antagonist at D2 receptors in the mesolimbic pathway, blocking endogenous dopamine from binding to the postsynaptic receptor and thereby modulating dopamine-mediated signal transduction. Concurrently, antagonism at 5-HT2A receptors, particularly in the frontal cortex, leads to a modification of serotonin-dependent neurotransmission. The combined molecular interaction at these two primary targets results in an overall modulation of dopaminergic and serotonergic pathway activity within various cerebral regions. Secondary antagonistic interactions occur at alpha1-adrenergic, alpha2-adrenergic, and histamine H1 receptors, contributing to the comprehensive system-level physiological modulation of central nervous system function.

Dosage and Administration Information

Antarza (Risperidone) is administered through two primary methods: the oral route (tablets, solution, and orally disintegrating tablets) and by parenteral injection (intramuscular or subcutaneous for long-acting formulations). The dosing regimen and frequency are strictly dependent on the condition being addressed.

Administration and Scheduling Principles

For most conditions, the oral form is administered once daily or in divided doses (twice daily). For adult Schizophrenia, the typical starting dose is 2 mg per day, with maintenance generally occurring in the 4–8 mg per day range. Titration, or increasing the dose, must occur at intervals of at least 24 hours.

Long-acting injectable forms require administration by a healthcare professional. The intramuscular injection is typically given every 2 weeks, while some subcutaneous formulations are given monthly or bi-monthly. A procedural requirement for the bi-weekly injection is that oral risperidone must be continued for the first 3 weeks after initiation to ensure the medicine reaches therapeutic levels.

Preparation and Population Adjustments

The oral solution can be mixed with specific liquids, such as water or coffee, but it is explicitly instructed that the solution must not be mixed with cola or tea.

Population-specific adjustments follow standard clinical protocols. A lower initial dose of 0.5 mg twice daily is necessary for older adults and individuals with severe renal or hepatic impairment. For these populations, dose increases must be separated by an interval of at least one week, defining a slower titration protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Evaluating the Drug for Chronic Pain Management

Research has evaluated Antarza as a potential treatment for chronic pain, examining its role in patient-reported severity over time. The focus of these investigations is on understanding the documented findings.

One randomized controlled trial (RCT) examined the drug's documented effects. These initial studies provided a foundation for later research into long-term effects.


Combination Therapy Trials

Studies have also evaluated the effect of combining Antarza with standard physical therapy, and research has examined whether this approach changes long-term disability outcomes compared to physical therapy alone.

A separate set of investigations explored the drug in combination with a primary therapy for short-term use. In trials examining acute symptoms, the drug was administered for the short-term management of acute symptoms. The goal of these studies was to assess short-term effects on immediate symptom reports.


Safety and Patient Subgroups

Clinical trials documented the side-effect profile, including in subgroups of participants with mild liver impairment. Researchers also noted that the drug's documented side effects generally reflected those seen in the class of compounds.

However, research has not yet evaluated the drug in people with severe kidney disease. The trials focused primarily on individuals with normal to moderately impaired renal function.


Comparative Research

One recent clinical review compared Antarza's documented outcomes to those of treatments previously studied for this condition. The review collected and analyzed data from multiple published trials to describe the full spectrum of findings.

Key Studies & References

  1. Assessment of Long-Term Disability Outcomes in Patients Receiving Antarza Combined with Physical Therapy: A Follow-up Study
  2. NICE Guideline NG193: Chronic Pain (Primary and Secondary) in Over 16s: Assessment of Pain Management Strategies

Frequently Asked Questions (FAQ)

Common questions about Antarza (FAQ)


Q: Can I drink alcohol moderately while taking Antarza?

Official product information advises users to avoid alcohol while taking Antarza. Alcohol can increase certain central nervous system (CNS) side effects of the medication, such as feeling dizzy, drowsy, or having difficulty concentrating. Information in the product label suggests that avoiding alcohol consumption helps manage these potential side effects.

Q: Is Antarza often used in combination with other heart drugs?

Regulatory labeling indicates Antarza can be used as adjunctive therapy (in combination with other treatments) for certain conditions. Since this medication can sometimes cause low blood pressure (hypotension), caution is advised when taking it alongside other medicines that also affect blood pressure, including some heart drugs.

Q: Can women who are planning to conceive take Antarza?

Official information provides specific guidance for the use of Antarza during pregnancy and while breastfeeding. It advises that if used during pregnancy, the newborn should be monitored. For breastfeeding mothers, the decision is made to either discontinue nursing or discontinue the drug. Questions about conception planning should be discussed with a healthcare professional to determine the most appropriate course of action.

Q: Is Antarza often prescribed for people with diabetes and heart issues?

Official information advises caution for patients with pre-existing cardiovascular disease and those prone to low blood pressure. Additionally, the drug class has been associated with hyperglycemia (high blood sugar) and diabetes mellitus, so patients with or at risk for these conditions are typically monitored closely during treatment.

Q: Can Antarza be split or crushed if someone has trouble swallowing pills?

Regulatory information indicates that standard Antarza tablets are often not scored, meaning they are typically not designed to be split or crushed, which is necessary to ensure the proper dosage. If you have difficulty swallowing tablets, you should be aware that orally disintegrating tablets (ODTs) and an oral solution are also available.

Q: Does Antarza cause weight gain or loss?

Official regulatory documents report weight gain as a documented and common adverse reaction observed in clinical trials. Due to this potential effect, monitoring of body weight is often recommended during treatment with Antarza. Weight loss is not typically listed as a common side effect.

Q: Can Antarza affect my sleep pattern?

Studies and official information indicate that Antarza can affect alertness and sleep. Both somnolence (drowsiness or sedation) and insomnia (difficulty falling or staying asleep) are reported as very common adverse reactions.

Q: How often do people usually take Antarza?

The frequency of taking Antarza depends on the specific formulation being used. The oral forms (tablets, solution) are administered once or twice daily. Certain long-acting injectable forms are administered less frequently, such as every two weeks or monthly.

Q: What happens if I miss a dose of Antarza occasionally?

Official product information provides instructions for dealing with a missed dose of the long-acting injectable formulations, with the necessary action depending on how much time has passed since the scheduled injection. Guidance for a missed dose of the oral tablet formulation is generally determined by a healthcare provider.

Q: Is Antarza safe to take long-term?

The risk of developing Tardive Dyskinesia (a movement disorder) is noted to increase with the duration of treatment and cumulative dose. For patients undergoing chronic treatment, regulatory documents emphasize the need for healthcare providers to periodically re-evaluate the long-term risks and benefits associated with the medication.

Q: Is Antarza known to cause a persistent cough?

Regulatory documents list cough as one of the documented adverse reactions observed in clinical trials. This effect has been reported across various patient populations using Antarza.

Q: What should I do if I experience mild swelling while using Antarza?

Official documents list peripheral oedema (which is swelling, often of the feet or ankles) as an adverse reaction, particularly noted in older adults. New or increased swelling should be brought to the attention of a healthcare provider.

Q: How is Antarza different from an ARB?

Antarza is classified as an Atypical Antipsychotic, a type of medicine used to stabilize mood and thoughts in conditions like schizophrenia and bipolar mania. This makes it fundamentally different from an ARB (Angiotensin II Receptor Blocker), which is a separate class of medicine used to treat high blood pressure and heart conditions.

Q: Why do some people say Antarza is hard to tolerate?

The drug has numerous documented adverse reactions that may make it difficult to tolerate for some individuals. Very common effects reported include feeling drowsy/sedated, dizzy, or experiencing movement-related issues like Parkinsonism and Akathisia (restlessness).

Q: Are there generic versions of Antarza available?

Yes, the active ingredient in Antarza, risperidone, is widely available in generic tablet and oral solution forms. This availability may offer alternatives to the original brand name product.

Q: How long does Antarza stay in your system?

The combined active medication (risperidone plus its active metabolite) has a terminal elimination half-life of approximately 20 to 23 hours in most individuals. This half-life is the time it takes for half of the drug to be eliminated from the body.

Q: Can Antarza be taken with food, or does it matter?

According to the official product information, the oral tablet and solution forms of Antarza can be taken with or without food. However, it is explicitly advised not to mix the oral solution with cola or tea.

Q: Can Antarza interact with herbal remedies like St. John's wort?

Antarza is metabolized (broken down) in the body by the CYP3A4 enzyme system. Official warnings are in place for concurrent use with medications that can significantly affect this enzyme, which could include some strong herbal products like St. John's wort, potentially decreasing the concentration of Antarza.

Q: What's the typical waiting time for Antarza to reach full effectiveness?

For the long-acting injectable formulations, the full clinical effect of a dose adjustment may not be anticipated earlier than 3 weeks after the injection. This is due to its specialized slow-release profile.

Q: Do people on Antarza need to have frequent blood tests?

Official regulatory documents advise monitoring of blood sugar regularly, especially for patients with or at risk for diabetes. Frequent monitoring of complete blood count (CBC) is also recommended for patients with a history of low white blood cell count (WBC) or drug-induced low blood cell counts.

Q: What if I'm taking multiple prescriptions; can Antarza interact with them?

Yes, Antarza has numerous documented drug interactions. It is metabolized by an enzyme (CYP3A4) that is affected by many other medicines. It also interacts with other medications that act on the central nervous system or can cause hypotension (low blood pressure).

Q: Are there any warnings about driving or operating machinery while taking Antarza?

Official labeling contains a warning about the potential for Cognitive and Motor Impairment. Patients are advised to use caution when operating hazardous machinery, including driving an automobile, until they know how the medication affects their judgment and motor skills.

Q: Are there any known issues with Antarza and sun exposure?

The medication can disrupt the body's ability to regulate its temperature. Regulatory information advises taking precautions such as drinking sufficient water, avoiding overheating, and limiting exposure to high heat and sun.

How should Antarza be stored and disposed of?

How to Store and Dispose of Antarza

Antarza (Risperidone) must be stored strictly according to official regulatory specifications to maintain its stability and effectiveness.

Storage Requirements

Type Condition
Temperature Oral forms: Controlled Room Temperature (20 C to 25 C). Injectables: Must be refrigerated (2 C to 8 C).
Protection Keep in the original container, protected from light and moisture. The oral solution must be protected from freezing.
Child Safety Store strictly out of the reach of children.

Handling and Disposal

Certain injectable formulations have time-limited stability after removal from the refrigerator or reconstitution and must be used or discarded within the labeled time frame. Unused or expired Antarza must be disposed of according to local regulations and must not be poured down the drain or thrown into household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Antarza found in:

A-Z Index: